A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients

Summary

The study is to evaluate the therapeutic effect of metformin as a maintenance therapy in high risk patients with complete remission of diffuse large B lymphoma / stage III follicular lymphoma after chemotherapy in the initial R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone, plus the monoclonal antibody rituximab) regimen

Timeline

Start

2018-09-01

Primary completion

2021-01

Completion

2021-12

Drugs

Indications